Demonstration of a Tubercular Fistula-in-Ano on F-18 FDG PET/CT

Garg, Gunjan; Tripathi, Madhavi; D’Souza, Maria; Jaimini, Abhinav; Jain, Nikunj Kumar; Khurana, Aditi; Sharma, Rajnish; Mondal, Anupam

doi:10.1097/rlu.0b013e3181d18ccb

Cited by 6 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The ability of PET/CT to delineate the sinus track without the need for contrast instillation is thus an added advantage of PET/CT and has been described in the past. [10] With the incorporation of contrast-enhanced computed tomography (CECT) in the PET/CT protocol, the complete extent of bone, bone marrow and soft tissue involvement can be delineated. More-over, metabolically active disease can be distinguished from residual fibrotic tissue.…”

Section: Discussionmentioning

confidence: 99%

F-18 Fluorodeoxyglucose positron emission tomography/computed tomography in tuberculosis of the hip: A case report and brief review of literature

et al. 2011

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

F-18 Fluorodeoxyglucose positron emission tomography/computed tomography in tuberculosis of the hip: A case report and brief review of literature

et al. 2011

View full text Add to dashboard Cite

“…All these cases had intense 18 F-FDG uptake, but imaging alone was insufficient to make the diagnosis. [111][112][113][114] Scrofuloderma where TB lymphadenitis affects the skin may be demonstrated on 18 F-FDG-PET/CT (Fig. 12).…”

Section: Ocular Tbmentioning

confidence: 99%

Tuberculosis

Ankrah

Glaudemans

Maes

et al. 2018

Seminars in Nuclear Medicine

View full text Add to dashboard Cite

Tuberculosis (TB) is currently the world's leading cause of infectious mortality. Imaging plays an important role in the management of this disease. The complex immune response of the human body to Mycobacterium tuberculosis results in a wide array of clinical manifestations, making clinical and radiological diagnosis challenging. F-FDG-PET/CT is very sensitive in the early detection of TB in most parts of the body; however, the lack of specificity is a major limitation.F-FDG-PET/CT images the whole body and provides a pre-therapeutic metabolic map of the infection, enabling clinicians to accurately assess the burden of disease. It enables the most appropriate site of biopsy to be selected, stages the infection, and detects disease in previously unknown sites. F-FDG-PET/CT has recently been shown to be able to identify a subset of patients with latent TB infection who have subclinical disease. Lung inflammation as detected byF-FDG-PET/CT has shown promising signs that it may be a useful predictor of progression from latent to active infection. A number of studies have identified imaging features that might improve the specificity of F-FDG-PET/CT at some sites of extrapulmonary TB. Other PET tracers have also been investigated for their use in TB, with some promising results. The potential role and future perspectives of PET/CT in imaging TB is considered. Literature abounds on the very important role ofF-FDG-PET/CT in assessing therapy response in TB. The use of F-FDG for monitoring response to treatment is addressed in a separate review.

show abstract

FDG PET/CT in TB: Mimics, Pitfalls, and Limitations

Šaranović

Stojiljković

2020

PET/CT in Tuberculosis

View full text Add to dashboard Cite

Demonstration of a Tubercular Fistula-in-Ano on F-18 FDG PET/CT

Cited by 6 publications

References 6 publications

F-18 Fluorodeoxyglucose positron emission tomography/computed tomography in tuberculosis of the hip: A case report and brief review of literature

F-18 Fluorodeoxyglucose positron emission tomography/computed tomography in tuberculosis of the hip: A case report and brief review of literature

Tuberculosis

FDG PET/CT in TB: Mimics, Pitfalls, and Limitations

Contact Info

Product

Resources

About